CGRP (Calcitonin Gene-Related Peptide) inhibitors are a class of medication designed to prevent and treat migraines by targeting the CGRP pathway. CGRP is a neuropeptide involved in the transmission of pain and the dilation of blood vessels in the brain. By blocking the action of CGRP, these inhibitors can reduce the frequency and severity of migraine attacks.
